Introduction of a radioactive gastrointestinal marker (5"CrC13) into a combined study ('5SeHCAT+58CoBl2) of ileal function by whole body counting has been undertaken. The technique was assessed in 23 subjects (15 patients with inflammatory bowel disease, six on non-steroidal anti-inflammatory drugs for rheumatoid arthritis, and two normal subjects). Mean (SD) 51CrC13 retention was only 4-1 (6.0)% on day 4, and was similar on day 7 in subjects given a second dose of "CrCl3 on day 4. Only one subject had more than 20% of 51CrC13 retention after four days. A 5"CrC13 correction method adequately corrected for colonic hold up of 5'CoB12, when compared with final equilibrium values of wCoBl2 retention. Use of the non-absorbed 58CoB12 fraction as a gastrointestinal marker gave good agreement with the 51CrCl3 method in correcting 75SeHCAT values. In all subjects studied, corrections for colonic retention of 71SeHCAT on day 4, were small (<7% of dose) and did not affect the assessment of any subject. In conclusion, an additional gastrointestinal marker such as 51CrCl3 is unnecessary in our combined study since that role can be effected, when indicated, by the non-absorbed 58CoB12 fraction.marker, 5"CrCI3,'5 to monitor and correct for colonic retention of 75SeHCAT measured by abdominal counting using a gamma camera.Vitamin B12 is also absorbed predominantly at the terminal ileum, but by a different mechanism to that for SeHCAT, and the combined use of radiolabelled B12 and SeHCAT has been successfully exploited by whole body counting.'6'0 In our combined study of 75SeHCAT and "8CoB12,6 it was suggested that analysis of the relative patterns of retention of the two test substances could be used to check for evidence of colonic retention. It was considered prudent, however, to attempt to apply the I'CrC13 gastrointestinal marker technique in our whole body counting protocol to substantiate this claim and furthermore to assess and quantify the influence of colonic retention on the overall results. We therefore incorporated "CrCl3, administered orally and together with 75SeHCAT and '8CoB12 (plus intrinsic factor), in our combined test of ileal function'6 to assess the efficiency of colonic emptying on three study days (days 4, 7, and 10), and to consider the prospects for correcting the "SeHCAT and '8CoB12, retention values in patients with inflammatory bowel disease and non-steroidal anti-inflammatory drug enteropathy.